The FinTech Hub
Source: Live Mint Buy or sell: Over the past three weeks, the Nifty Index has demonstrated a strong recovery, fueled by Foreign Institutional Investors (FIIs) purchasing stocks worth ₹30,000 crore in the cash market. This bullish momentum was underpinned by both global and domestic factors, notably U.S. President Donald Trump’s decision to pause the implementation…
Source: Live Mint Buy or Sell: The Nifty Index ended the week at 23,519, holding firmly above the critical support level of 23,000. The Indian stock market closed with marginal gains, but investor sentiment remained subdued due to concerns surrounding U.S. economic indicators and trade policies. Also Read | Wipro’s mega deal win ushers confidence,…
Source: Live Mint Stock Market Today: Indian pharma stocks faced significant selling pressure in today’s session, February 10, driven by weak earnings in select companies and fears that former U.S. President Donald Trump could introduce a universal trade tariff of at least 10% on all imports, potentially affecting pharmaceutical exports. As a result, 19 out…
Source: Live Mint Q2 results today on November 9: At least 88 companies are set to release their July-September quarter financial results today, on Friday, November 9, according to BSE data. Further, several major blue-chip firms and banks are scheduled to declare their Q2 results this week. The second quarter results (Q2FY25) season began last…
Source: Live Mint Buy or sell: As discussed last week, both the Nifty and Bank Nifty indices were in overbought conditions, resulting in a significant correction over the past week. The Nifty index dropped by nearly 5%, closing at 25,014, while the Bank Nifty corrected by about 6%, ending at 51,462. The Federal Reserve’s decision…
Source: Business Standard Aurobindo Pharma share price today 2 min read Last Updated : Sep 30 2024 | 2:38 PM IST Aurobindo Pharma share declined 4.3 per cent today, logging an intraday low of Rs 1,443.5 per share on the BSE. The scrip dropped after the US Food and Drugs Administration (USFDA) inspected Apitoria Pharma,…
